Synthesis and biological evaluation of 2-(arylethynyl)quinoline derivatives as mGluR5 antagonists for the treatment of neuropathic pain
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Myung-Hee | - |
dc.contributor.author | Kim, Ji Young | - |
dc.contributor.author | Lim, Eun Jeong | - |
dc.contributor.author | Baek, Du-Jong | - |
dc.contributor.author | Choi, Kihang | - |
dc.contributor.author | Lee, Jae Kyun | - |
dc.contributor.author | Pae, Ae Nim | - |
dc.contributor.author | Min, Sun-Joon | - |
dc.contributor.author | Cho, Yong Seo | - |
dc.date.accessioned | 2021-09-06T03:44:03Z | - |
dc.date.available | 2021-09-06T03:44:03Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-03-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/103779 | - |
dc.description.abstract | We described here the synthesis and biological evaluation of mGluR5 antagonists containing a quinoline ring structure. Using intracellular calcium mobilization assay (FDSS assay), we identified compound 5n, showing high inhibitory activity against mGluR5. In addition, it was found that compound 5n has excellent stability profile. Finally, this compound exhibited favorable analgesic effects in spinal nerve ligation model of neuropathic pain, which is comparable to gabapentin. (c) 2012 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | METABOTROPIC GLUTAMATE RECEPTORS | - |
dc.subject | RAT MODEL | - |
dc.subject | 2-METHYL-6-(PHENYLETHYNYL)-PYRIDINE MPEP | - |
dc.subject | ALLOSTERIC MODULATORS | - |
dc.subject | POTENT | - |
dc.subject | ALLODYNIA | - |
dc.subject | COGNITION | - |
dc.subject | DISEASE | - |
dc.subject | ANXIETY | - |
dc.title | Synthesis and biological evaluation of 2-(arylethynyl)quinoline derivatives as mGluR5 antagonists for the treatment of neuropathic pain | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Kihang | - |
dc.identifier.doi | 10.1016/j.bmcl.2012.12.056 | - |
dc.identifier.scopusid | 2-s2.0-84873744551 | - |
dc.identifier.wosid | 000314693400064 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.23, no.5, pp.1472 - 1476 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 23 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1472 | - |
dc.citation.endPage | 1476 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | METABOTROPIC GLUTAMATE RECEPTORS | - |
dc.subject.keywordPlus | RAT MODEL | - |
dc.subject.keywordPlus | 2-METHYL-6-(PHENYLETHYNYL)-PYRIDINE MPEP | - |
dc.subject.keywordPlus | ALLOSTERIC MODULATORS | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordPlus | ALLODYNIA | - |
dc.subject.keywordPlus | COGNITION | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | ANXIETY | - |
dc.subject.keywordAuthor | Metabotropic glutamate receptor | - |
dc.subject.keywordAuthor | Antagonist | - |
dc.subject.keywordAuthor | Quinoline | - |
dc.subject.keywordAuthor | Sonogashira reaction | - |
dc.subject.keywordAuthor | Neuropathic pain | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.